Plenary and opening welcome to Psychedelic Science 2017 - Rick Doblin, PhD, Amanda Feilding, and Beatriz Labate, PhD.
01:11:17 min
CLEAR ALL
Psychedelics have an ancient and more recent history of medicinal-use. Administered in a supportive environment, with preparatory and integrative psychological care, psychedelic medicines are now being used to facilitate emotional breakthrough and renewed perspective.
1
MDMA, better known as ecstasy, molly, or one of a number of other street names, is a stimulant drug with unique prosocial effects. In this video, I discuss the current understanding of how MDMA acts on the brain to produce its effects.
Paul Stamets has been studying psilocybin mushrooms since the mid 1970's. Having written 6 books, including two field guides to psilocybin mushrooms, Paul has named four new psilocybin-active mushroom species.
Scientists have discovered that the brain structures of traumatised soldiers and children change in the same way. Subscribe to BBC News HERE http://bit.ly/1rbfUog Check out our website: http://www.bbc.com/news Facebook: http://www.facebook.com/bbcworldnews Twitter: http://www.twitter.
Riane Eisler joins the Thom Hartmann program, warning that we are in regression and that we can still make progress, if we handle regressions from human rights victories, like the election of Donald Trump.
The Neurophenomenology of the DMT State, presented by Christopher Timmermann from Imperial College London, UK
Dr Robin Carhart-Harris talks about his scientific research into the effects and potential therapeutic uses of psychedelic drugs. Join him as he discusses brain imaging work involving psilocybin, the active ingredient of magic mushrooms, and explains how the drug works in the brain.
Abstract: Highlighting the results of two fMRI studies and one MEG study with psilocybin and an fMRI study with MDMA, Carhart-Harris will report the effects of both drugs on regional brain activity and brain network organization.
Dr. Robin Carhart-Harris, of the Neuropsychopharmacology Unit, Imperial College London, discusses research on Psilocybin and how psychedelics could be used in therapy to help with depression, addiction, and other problems of rigid thought patterns.
Daniel Amen wants to see the end of mental illness, and he may very well achieve his goal.
2